Stock 000930 COFCO BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials COFCO Biotechnology Co., Ltd.

Equities

000930

CNE000000ZR7

Diversified Chemicals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
6.24 CNY -1.58% Intraday chart for COFCO Biotechnology Co., Ltd. -3.11% -6.02%
Apr. 24 COFCO Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 24 COFCO Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 12,194 15,710 20,280 15,594 12,382 11,636 - -
Enterprise Value (EV) 1 12,194 15,710 20,280 15,594 12,382 11,636 11,636 11,636
P/E ratio 20.6 x 26.2 x 17.8 x 14.7 x -20.3 x 156 x 24 x 16.4 x
Yield - - - - - - - -
Capitalization / Revenue 0.63 x 0.79 x 0.86 x 0.78 x - 0.57 x 0.56 x 0.54 x
EV / Revenue 0.63 x 0.79 x 0.86 x 0.78 x - 0.57 x 0.56 x 0.54 x
EV / EBITDA 11 x 12.4 x 11.1 x 8.63 x - 15.2 x 9.72 x 8.46 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 1.24 x 1.51 x 1.78 x 1.29 x - 1.1 x 1.06 x 1.02 x
Nbr of stocks (in thousands) 1,847,644 1,865,764 1,865,718 1,865,274 1,864,721 1,864,721 - -
Reference price 2 6.600 8.420 10.87 8.360 6.640 6.240 6.240 6.240
Announcement Date 4/13/20 4/14/21 4/28/22 4/14/23 4/24/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19,472 19,909 23,469 19,918 - 20,404 20,659 21,543
EBITDA 1 1,105 1,268 1,833 1,808 - 767 1,197 1,376
EBIT 1 660 806.3 1,381 1,350 - 75 501 689
Operating Margin 3.39% 4.05% 5.88% 6.78% - 0.37% 2.43% 3.2%
Earnings before Tax (EBT) 1 666.3 801.9 1,383 1,360 - 89 519 709
Net income 1 592.8 593.1 1,133 1,059 -601.6 81 488 705
Net margin 3.04% 2.98% 4.83% 5.32% - 0.4% 2.36% 3.27%
EPS 2 0.3209 0.3209 0.6109 0.5700 -0.3267 0.0400 0.2600 0.3800
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 4/13/20 4/14/21 4/28/22 4/14/23 4/24/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 6.21% 5.86% 10.4% 9.02% - 0.8% 4.4% 6.2%
ROA (Net income/ Total Assets) - - 5.88% - - 0.5% 2.9% 4%
Assets 1 - - 19,273 - - 16,200 16,828 17,625
Book Value Per Share 2 5.320 5.570 6.110 6.490 - 5.650 5.890 6.140
Cash Flow per Share 1.980 -1.560 2.600 0.3800 - - - -
Capex 1 901 - 839 - - 200 200 200
Capex / Sales 4.63% - 3.58% - - 0.98% 0.97% 0.93%
Announcement Date 4/13/20 4/14/21 4/28/22 4/14/23 4/24/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.24 CNY
Average target price
8 CNY
Spread / Average Target
+28.21%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
COFCO BIOTECHNOLOGY CO., LTD. Stock COFCO Biotechnology Co., Ltd.
-6.02% 1.61B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
-0.47% 76.05B
BASF SE Stock BASF SE
-2.81% 46.81B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
+6.71% 34.32B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+11.86% 18.63B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+12.15% 11.85B
SYENSQO SA/NV Stock Syensqo SA/NV
-3.86% 10.63B
BRENNTAG SE Stock Brenntag SE
-22.37% 10.28B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
-1.06% 9.27B
SRF LIMITED Stock SRF Limited
-9.70% 8.12B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. 000930 Stock
  4. Financials COFCO Biotechnology Co., Ltd.